CECBF yields 4000000.00% · JNJ yields 2.14%● Live data
📍 CECBF pulled ahead of the other in Year 1
Combined, CECBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CECBF + JNJ for your $10,000?
Saltbae Capital Corp., together with its subsidiaries, engages in the exploration of mineral properties in the United States. The company primarily explores for vanadium. It holds 100% interest in Bisoni Mackay and Bisoni-Rio properties that covers 4,115 acres of vanadium claims in Nye County, Nevada. The company offers turnkey engineering and electrical solutions and equipment, such as electrical switchgears, motor control switchers, and solar power inverters for heavy power users, pipeline companies, refineries, manufacturers, municipalities, and infrastructure providers. It also provides CellCubes, a vanadium flow battery that are used in grid storages, micro-grids, off-grid for solar and wind power storages, diesel power replacements, back-up power systems, farming applications, electrical vehicle charging stations, industrial plants, office building applications, emergency power sources, and others. The company was formerly known as CellCube Energy Storage Systems Inc. and changed its name to Saltbae Capital Corp. in June 2021. Saltbae Capital Corp. was incorporated in 1986 and is headquartered in Toronto, Canada.
Full CECBF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.